Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00938145 · ClinicalTrials.gov registry record · NA

3 Tesla MRI in Patients With Bladder Cancer

A NA study of Bladder Cancer, sponsored by University of Cincinnati.

Active
Registry status
NA
Development phase
98
Enrollment target
1
Study location

NCT00938145 is a NA study of Bladder Cancer that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 98 participants, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00938145, a NA study of Bladder Cancer, is active but no longer recruiting, sponsored by University of Cincinnati.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
98 participants
Enrollment target
1
Study location

Study Summary

RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease. PURPOSE: This clinical trial is studying how well 3 Tesla MRI works in finding cancer in patients with bladder cancer.

Conditions Studied

Interventions

  • PROCEDURE Specimen Ultra-High field MRI
  • DRUG chemotherapy
  • PROCEDURE Cystectomy and Lymphadenectomy

Study Locations (1)

Ohio

  • Ohio State University Medical Center - Columbus

Trial Details

FieldValue
Enrollment Target 98 participants
Start Date 2009-07-08
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Cincinnati

245 total trials

What the Registry Record Tells You About NCT00938145

The ClinicalTrials.gov registry entry for NCT00938145 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 98 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,753-participant average among 175 other Bladder Cancer trials with a reported enrollment target (99% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Bladder Cancer appearing as the primary indexed condition, and to 3 interventions - of which Specimen Ultra-High field MRI is the first listed.

NCT00938145 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00938145 about?

NCT00938145 is a clinical study titled "3 Tesla MRI in Patients With Bladder Cancer". RATIONALE: New diagnostic procedures, such as 3 Tesla magnetic resonance imaging (MRI), may help find bladder cancer and learn the extent of disease. PURPOSE: This clinical trial is studying how well 3 Tesla MRI works in finding cancer in patients with bladder cancer.

What is the current status of trial NCT00938145?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 98 participants. The study started on 2009-07-08. Estimated completion is 2026-12-31.

What conditions does trial NCT00938145 study?

This clinical trial studies the following conditions: Bladder Cancer.

What interventions are being tested in trial NCT00938145?

The interventions under investigation include: Specimen Ultra-High field MRI (PROCEDURE), chemotherapy (DRUG), Cystectomy and Lymphadenectomy (PROCEDURE).

Who is sponsoring clinical trial NCT00938145?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00938145 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bladder Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.